Revvity, Inc. (RVTY) |
|
109.23 0.3 (0.28%)
|
09-27 10:53 |
|
Open: |
109.35 |
Pre. Close: |
108.93 |
|
High:
|
109.94 |
Low:
|
108.9 |
|
Volume:
|
41,387 |
Market Cap:
|
13,559(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 10:19:08 AM |
|
Short-term rate:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 133.58 One year: 139.75 |
| Support: |
Support1: 105.83 Support2: 88.05 |
| Resistance: |
Resistance1: 114.37 Resistance2: 119.65 |
| Pivot: |
110.18  |
| Moving Average: |
MA(5): 109.54 MA(20): 111.51
MA(100): 117.55 MA(250): 126.75 |
| MACD: |
MACD(12,26): -2 Signal(9): -2.1 |
| Stochastic oscillator: |
%K(14,3): 37.9 %D(3): 34.5 |
| RSI: |
RSI(14): 42.4 |
| 52-week: |
High: 150.16 Low: 105.83 |
| Average Vol(K): |
3-Month: 699 (K) 10-Days: 559 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RVTY ] has closed above bottom band by 46.3%. Bollinger Bands are 42.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
110.94 - 111.58 |
111.58 - 112.15 |
|
Low:
|
107.46 - 108.16 |
108.16 - 108.79 |
|
Close:
|
107.94 - 109.04 |
109.04 - 110.04 |
|
Company Description |
|
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. |
Headline News |
Tue, 26 Sep 2023
Analyst Reaffirms Positive Outlook on Qiagen with 60 Target Price - Best Stocks
Tue, 26 Sep 2023
2023-09-26 | NYSE:RVTY | Press Release | Revvity Inc - Stockhouse Publishing
Thu, 21 Sep 2023
SPYX's Underlying Holdings Could Mean 16% Gain Potential - Nasdaq
Wed, 20 Sep 2023
Assessing Agilent Technologies Incs PE Ratio and Market ... - Best Stocks
Mon, 18 Sep 2023
Bruker Corporation Revolutionizes Proteomics with Groundbreaking ... - Best Stocks
Sun, 17 Sep 2023
What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing? - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
124 (M) |
| Shares Float |
112 (M) |
|
% Held by Insiders
|
0.3 (%) |
|
% Held by Institutions
|
87.5 (%) |
|
Shares Short
|
2,930 (K) |
|
Shares Short P.Month
|
3,130 (K) |
Stock Financials |
|
EPS
|
1.99 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
63.29 |
|
Profit Margin (%)
|
28.8 |
|
Operating Margin (%)
|
17.5 |
|
Return on Assets (ttm)
|
2.1 |
|
Return on Equity (ttm)
|
3.3 |
|
Qtrly Rev. Growth
|
-20.8 |
|
Gross Profit (p.s.)
|
16.43 |
|
Sales Per Share
|
22.87 |
|
EBITDA (p.s.)
|
7.45 |
|
Qtrly Earnings Growth
|
-80 |
|
Operating Cash Flow
|
227 (M) |
|
Levered Free Cash Flow
|
799 (M) |
Stock Valuations |
|
PE Ratio
|
55.23 |
|
PEG Ratio
|
-5.1 |
|
Price to Book value
|
1.73 |
|
Price to Sales
|
4.8 |
|
Price to Cash Flow
|
60.04 |
Stock Dividends |
|
Dividend
|
0.07 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
